MoonLake Immunotherapeutics (MLTXN.MX) Q4 2024 Earnings

7NovConfirmed
Q4 2024
-11.08
-10.26
-9.44
-8.62

Details

Expected EPS
-8.618382804800001
Actual EPS
-11.082904000000001
Surprise EPS
-2.46
Surprise Percent
+28.6%

Description

MoonLake Immunotherapeutics (MLTXN.MX) has reported earnings of -11.082904000000001 per share for Q4 2024.

0 Comments

Share your thoughts